首页 | 本学科首页   官方微博 | 高级检索  
     

自体造血干细胞回输治疗Ⅰ型糖尿病2例
引用本文:景华,陈文怡,李克良,甄二真. 自体造血干细胞回输治疗Ⅰ型糖尿病2例[J]. 东南国防医药, 2009, 11(3): 202-205
作者姓名:景华  陈文怡  李克良  甄二真
作者单位:解放军第455医院干细胞移植中心,上海,200052
摘    要:
目的观察采用自体造血干细胞回输治疗Ⅰ型糖尿病的临床疗效。方法提取自体造血干细胞后,行T淋巴系统清除,再行干细胞回输,重建T淋巴系统,以清除原免疫系统对胰岛细胞的自身免疫反应,恢复胰岛细胞功能。结果2例患儿分别于干细胞回输后第14天、第20天停用胰岛素,安全出院。随访7个月,各项检查指标均正常。结论T淋巴系统清除和自体造血干细胞重建治疗为临床治疗Ⅰ型糖尿病提供了一种新方法,近期疗效好。

关 键 词:Ⅰ型糖尿病  自体造血干细胞移植  T淋巴系统清除

A new method of type 1 diabetes treatment:T lymphocytic series clearance and autologous hematopoietic stem cell transplantation(2 cases analysis)
JING Hua,CHEN Wen-yi,LI Ke-liang,XUE Er-zhen. A new method of type 1 diabetes treatment:T lymphocytic series clearance and autologous hematopoietic stem cell transplantation(2 cases analysis)[J]. Journal of Southeast China National Defence Medical Science, 2009, 11(3): 202-205
Authors:JING Hua  CHEN Wen-yi  LI Ke-liang  XUE Er-zhen
Affiliation:JING Hua,CHEN Wen-yi,LI Ke-liang,XUE Er-zhen(Department of blood stem cell transplantation,the 455th Hospital of PLA,Shanghai 200052,China)
Abstract:
Objective To analyze the safety and effect of T lymphocytic series clearance and autologous hematopoietic stem cell transplantation(AHSCT) for type 1 diabetes(T1D).Methods Two newly diagnosed T1D patients were managed by a low dose immuno-suppression regimen followed by AHSCT.Results In the two cases,insulin injection was stopped at 14 days and 20 days respectively after AHSCT,and discharged safely.In 7-month follow-up, their blood glucose level was normal without insulin.Conclusion The clinical outcome sho...
Keywords:Type 1 diabete  Autologous hematopoietic stem cell transplantation  T lymphocytic series clearance  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号